Keywords: novartis, zometa, backed, treatment, bone, metastases, usa

Novartis' Zometa backed for treatment of bone metastases in USA

Article | 11 February 2002

Print This

Novartis of Switzerland moved a step closer to offering the firstbisphosphonate treatment for bone metastases in a wide range of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in